Active Research

PI

CO-
PI and Study Title

Sponsor

Dates

Gedaly, Roberto Switching Study of Kidney Transplant Patients with Tremor to LCP-
Tacro (STRATO)
United Biosource Corp 04/10/2012 -
01/31/2015
Gedaly, Roberto A Randomized, Placebo Controlled, Double-
Blind Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus
Wyeth Pharmaceuticals Inc 02/08/2008 -
07/31/2012
Gedaly, Roberto A Facilitated Access Program to Provide Everlimus (RAD) for Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation Novartis 10/12/2007 -
12/31/2012
Gedaly, Roberto A 24 Month, Multi-
Center, Open-
Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-
Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients
Novartis 07/01/2008 -
10/15/2012
Gedaly, Roberto Planned Transition to Sirolimus-
Based Therapy vs. Continued Tacrolimus-
Based Therapy in Renal Allograft Recipients
Wyeth Pharmaceuticals Inc 10/08/2009 -
09/30/2012
Malluche, Martmut (Int Med -
Nephrology)
CO-PI: Roberto Gedaly

Effects of Zortress® + Tacrolimus (Everolimua) versus Standard Immunosuppression Therapy on Progression of Coronary Artery Calcifications in Patients with Renal Transplantation

Novartis 12/16/2012 -
12/31/2013
Waid, Thomas A Two Part, Phase 1/2, Safety, PK and PD Study of TOL 101, an Anti-
TCR Monoclonal Antibody for Prophylaxsis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Tolera Therapeutics Incorporated 12/09/2010 -
12/31/2015
X
Enter your Surgery username.
Enter the password that accompanies your username.
Loading